Solventum (SOLV) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Solventum (SOLV) do?
Solventum Corp (SOLV) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Sells advanced wound care dressings, dental restoratives, hospital filtration hardware, and medical billing software. Spun out from 3M, it manufactures specialized hospital wound dressings, dental composites, and clinical coding software. It is worth $14.56B on the market and sold $8.18B over the last year.
- Market cap
- $14.56B
- P/E ratio
- 96.1×
- Annual sales
- $8.18B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 13, 2026
Brands and businesses behind SOLV
- Tegaderm: Transparent film and wound dressings sold to hospitals to secure intravenous lines and protect healing skin.
- Filtek: Dental restorative materials sold to dental clinics for filling cavities and repairing tooth structures.
- Cavilon: Barrier films and skin protectants sold to healthcare providers to prevent tissue breakdown from moisture.
- RelyX: Dental cements sold to dental practitioners to bond crowns, bridges, and orthodontic appliances.
SOLV’s flags, in plain English
Each flag is a number from Solventum’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.
Wide Gross Margin
Gross margin of 55.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Insiders Hold
Insiders own 15.3% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Earnings Jumping
Profits up 18.6% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Priced for Perfection
Priced at 96.1 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about SOLV
How big is Solventum?
Solventum’s market cap is $14.56B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $8.18B: what customers paid the company over the last year, before any costs.
What is SOLV’s P/E ratio?
SOLV’s P/E ratio is 96.1×. Investors pay about 96.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with SOLV?
The company carries over eight billion dollars in total debt resulting from its separation from 3M. That is one risk on Solventum’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Solventum’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SOLV’s filings on SEC.gov. The Margin Monkey is research, not advice.
